INmune Bio Inc. (INMB)
Nasdaq: INMB · Biological Products, (No Diagnostic Substances) · Boca Raton, FL · filing with the SEC since 2017
Filings
458 filings since 2017 beside 143 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 23, 2026.
Filings a yearinsider forms included
105701085854807128
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Sep 14, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest May 7, 2025.SEC letters: 4 in the last 36 months, the newest Aug 5, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 29, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Oct 27, 2026
Oct 21, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Sep 14, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Sep 8, 2026
Jun 17, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 16, 2026
May 5, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Apr 29, 2026
Dec 8, 2025
8-K items 1.01, 3.03, 9.01
Major agreement signed; Change to shareholders' rights · Current report
Dec 5, 2025
Nov 18, 2025
8-K items 5.02, 5.07, 8.01, 9.01
Officer or director change; Shareholder vote; Other event · Current report
40 of 458 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.